HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&G sustainability

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble will generate "at least $20 bil. in cumulative sales of products with reduced environmental impact over the next five years," company announces Oct. 25. "This renewed commitment and new goals are designed to ensure P&G can continue to grow reliably and responsibly, just as we've done for the past 170 years," Director of Global Sustainability Peter White says. Over the next five years, P&G also is dedicated to reducing its water consumption, energy use, CO2 emissions and disposed waste per unit of production by 10% each, with the goal of achieving a 40% reduction over the 2002-2012 period. P&G also aspires to challenge its employees to "build sustainability thinking and practices" into their work, to continue collaborating on sustainability issues with the World Health Organization and other organizations, and to advance its social responsibility programs such as the Children's Safe Drinking Water program...

You may also be interested in...



Focus On Environmental Sustainability Here To Stay, Says P&G

While the corporate sustainability "pendulum" has oscillated for decades between social and environmental concerns, Procter & Gamble believes that going forward sustainability programs will focus primarily on the latter

Novo Executive Calls For ‘Real AMR Action’ In Davos

The Novo Nordisk Foundation is sponsoring a panel at Davos this week on finding solutions to the global crisis on antimicrobial resistance – and hopes world leaders will listen.

Roche Gears Up For Potential Neuroscience Breakthroughs

Neuroscience could be this decade’s big growth story, but clinical and market access challenges differ to oncology.

UsernamePublicRestriction

Register

RS015061

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel